drugset
drugset / Trial / NCT04952506

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

NCT04952506 ↗

Phase 1 Completed 25 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, single dosing, 3-treatment, 6-sequence, 3-period, crossover-design study to compare the pharmacokinetics and safety of D113 with CKD-349 in healthy volunteers.

Timeline

Start
2021-07-19
Primary completion
2021-07-29
Completion
2021-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-349 F1 Unknown — —
Subject CKD-349 F2 Unknown — —
Subject D113 Unknown — —

Indications

chronic renal failure syndrome